Agile Therapeutics reported $-105000 in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Bayer BAYN:GR EUR 7.03B 105M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
JAZZ PHA JAZZ:US USD 806.99M 1.68M
Johnson & Johnson JNJ:US USD 15.94B 56M
Merk MRK:US USD 10.47B 610M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Pfizer PFE:US USD 14.47B 2.08B
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
Therapeuticsmd TXMD:US USD 17.13M 6.69M